Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded
- Contract number
- SPE2DB25FEZMZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,219
Award facts
- Contract value 100% obligated
- $20,218.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,218.51 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3 mL) with an ultimate completion date of August 12, 2025. This non-set-aside competitive award was executed on August 11, 2025, with place of performance in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, demonstrates substantial capability in federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialized healthcare commodities. The company's contract awards with the Defense Logistics Agency span multiple therapeutic domains and reflect consistent competitively-awarded delivery orders with firm fixed pricing. This specific award for Ozempic, a diabetes medication, exemplifies AmerisourceBergen's role as a critical vendor supporting military and veteran healthcare systems through the DLA Medical Supply Chain, positioning the company to potentially participate in the Defense Logistics Agency's planned Pharmaceutical Prime Vendor Global Program Generation V contracts across multiple regions.
Quick answers
Who was awarded contract SPE2DB25FEZMZ?
SPE2DB25FEZMZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FEZMZ worth?
The government has obligated $20,219 on SPE2DB25FEZMZ.
Is contract SPE2DB25FEZMZ an order under another contract?
Yes. SPE2DB25FEZMZ is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FEZMZ competed?
The extent of competition for SPE2DB25FEZMZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award